INSIDER · CIK 2122447
Smith Darren Charlton
Group Chief Financial Officer at Telix Pharmaceuticals Ltd (TLX)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$20KBought on the market
$0.00Sold on the market
1Companies
Sep 14, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 202619:20 | Sep 7, 2026 | TLXTelix Pharmaceuticals Ltd | Group Chief Financial Officer | P · BuyLate 7d | $9.66 | +2,071 | 13,992 | +17% | +$20K | -22.3% | -1.5% |